Literature DB >> 925688

Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material.

K Jellinger, P Riederer.   

Abstract

Spectrofluorometric assays of DA, 5-HT and 5-HIAA were performed in different areas of postmortem brains of humans who died in hepatic and uremic coma. Brain DA showed a mild general decrease, the average reduction being 20 to 30 percent of the controls. By contrast, 5-HT and 5-HIAA were markedly increased in most brain areas, most significantly in the reticular and raphé nuclei of the brainstem and in some parts of the limbic system. Despite individual and regional differences, the monoamine changes had similar patterns in both hepatic and uremic coma. These data in human brain which confirm previous clinical and experimental studies in hepatic encephalopathy suggest some common disorders of central monoamine metabolism in endotoxic coma of different origin. Brain edema, a constant feature in toxic coma, is probably due to increased 5-HT content in the brain, the pathophysiologic effect of 5-HT on the blood-brain barrier being well established. The prominent changes of indoleamine metabolism in the reticular brainstem and limbic systems may be related to disorders of consciousness.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925688     DOI: 10.1007/bf01252022

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  25 in total

1.  The pathology of cerebral edema.

Authors:  H J Manz
Journal:  Hum Pathol       Date:  1974-05       Impact factor: 3.466

2.  Depletion of brain norepinephrine in acute hepatic coma.

Authors:  J M Dodsworth; J H James; M C Cummings; J F Fischer
Journal:  Surgery       Date:  1974-06       Impact factor: 3.982

3.  The astrocyte response in experimental portal-systemic encephalopathy: an electron microscopic study.

Authors:  M D Norenberg; L W Lapham
Journal:  J Neuropathol Exp Neurol       Date:  1974-07       Impact factor: 3.685

Review 4.  [Pathology of central nervous system disorders in internal diseases].

Authors:  K Jellinger
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1971

5.  Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions.

Authors:  P J Knott; G Curzon
Journal:  J Neurochem       Date:  1974-06       Impact factor: 5.372

6.  [Toxic metabolites in the brain of patients with liver cirrhosis and portocaval shunt].

Authors:  P Lesch
Journal:  Dtsch Med Wochenschr       Date:  1973-10-12       Impact factor: 0.628

7.  [Brain edema. A cause of death in endogenous hepatic coma].

Authors:  H Thölen
Journal:  Klin Wochenschr       Date:  1972-03-15

8.  Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).

Authors:  T L Sourkes; S N Young; E Garelis; S Lal
Journal:  Acta Vitaminol Enzymol       Date:  1975

Review 9.  The blood-brain barrier to horseradish peroxidase under normal and experimental conditions.

Authors:  E Westergaard
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

10.  Phenolic acids in experimental uremia. I. Potential role of phenolic acids in the neurological manifestations of uremia.

Authors:  N B Record; J W Prichard; B B Gallagher; D Seligson
Journal:  Arch Neurol       Date:  1969-10
View more
  7 in total

1.  Brain monoamines in human hepatic encephalopathy.

Authors:  K Jellinger; P Riederer; G Kleinberger; S Wuketich; P Kothbauer
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

2.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

3.  Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.

Authors:  G Bucht; R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 4.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

5.  Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.

Authors:  M Rössle; M Luft; R Herz; B Klein; M Lehmann; W Gerok
Journal:  Klin Wochenschr       Date:  1984-09-17

Review 6.  Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.

Authors:  R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Authors:  Miklós Palkovits; Katarína Šebeková; Kristina Simon Klenovics; Anton Kebis; Gholamreza Fazeli; Udo Bahner; August Heidland
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.